ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,477,000 | -52.4% | 42,200 | -23.3% | 0.01% | -50.0% |
| Q2 2019 | $3,103,000 | -22.8% | 55,000 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $4,018,000 | +14.5% | 55,000 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $3,508,000 | -36.1% | 55,000 | 0.0% | 0.02% | -25.0% |
| Q3 2018 | $5,487,000 | +40.4% | 55,000 | 0.0% | 0.02% | +33.3% |
| Q2 2018 | $3,907,000 | -31.7% | 55,000 | 0.0% | 0.02% | -31.8% |
| Q1 2018 | $5,724,000 | +3.3% | 55,000 | 0.0% | 0.02% | +4.8% |
| Q4 2017 | $5,540,000 | +188.2% | 55,000 | 0.0% | 0.02% | +162.5% |
| Q3 2017 | $1,922,000 | – | 55,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |